{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:48:22Z","timestamp":1790232502955,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Health and Medical Council of Australia","award":["?"],"award-info":[{"award-number":["?"]}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["P30 CA023074"],"award-info":[{"award-number":["P30 CA023074"]}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["?"],"award-info":[{"award-number":["?"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["?"],"award-info":[{"award-number":["?"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"crossref","award":["?"],"award-info":[{"award-number":["?"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00520-020-05616-5","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T13:50:08Z","timestamp":1594734608000},"page":"1377-1386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Correlates of cognitive impairment in adult cancer survivors who have received chemotherapy and report cognitive problems"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-3917","authenticated-orcid":false,"given":"Shannon L.","family":"Gutenkunst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5739-5790","authenticated-orcid":false,"given":"Janette L.","family":"Vardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4039-5169","authenticated-orcid":false,"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-4094","authenticated-orcid":false,"given":"Melanie L.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"5616_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","volume":"377","author":"MP Coleman","year":"2011","unstructured":"Coleman MP, Forman D, Bryant H et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet (Lond, Engl) 377:127\u2013138. https:\/\/doi.org\/10.1016\/S0140-6736(10)62231-3","journal-title":"Lancet (Lond, Engl)"},{"key":"5616_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11764-009-0098-x","volume":"3","author":"N Boykoff","year":"2009","unstructured":"Boykoff N, Moieni M, Subramanian SK (2009) Confronting chemobrain: an in-depth look at survivors\u2019 reports of impact on work, social networks, and health care response. J Cancer Surviv 3:223\u2013232. https:\/\/doi.org\/10.1007\/s11764-009-0098-x","journal-title":"J Cancer Surviv"},{"key":"5616_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.critrevonc.2007.06.001","volume":"63","author":"J Vardy","year":"2007","unstructured":"Vardy J, Tannock I (2007) Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 63:183\u2013202. https:\/\/doi.org\/10.1016\/j.critrevonc.2007.06.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"5616_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-010-0756-8","volume":"121","author":"J Debess","year":"2010","unstructured":"Debess J, Riis J\u00d8, Engebjerg MC, Ewertz M (2010) Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study. Breast Cancer Res Treat 121:91\u2013100. https:\/\/doi.org\/10.1007\/s10549-010-0756-8","journal-title":"Breast Cancer Res Treat"},{"key":"5616_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/pon.1398","volume":"18","author":"M Mehlsen","year":"2009","unstructured":"Mehlsen M, Pedersen AD, Jensen AB, Zachariae R (2009) No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psychooncology 18:248\u2013257. https:\/\/doi.org\/10.1002\/pon.1398","journal-title":"Psychooncology"},{"key":"5616_CR6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/sj.bjc.6603029","volume":"94","author":"V Jenkins","year":"2006","unstructured":"Jenkins V, Shilling V, Deutsch G, Bloomfield D, Morris R, Allan S, Bishop H, Hodson N, Mitra S, Sadler G, Shah E, Stein R, Whitehead S, Winstanley J (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 94:828\u2013834. https:\/\/doi.org\/10.1038\/sj.bjc.6603029","journal-title":"Br J Cancer"},{"key":"5616_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1470-2045(10)70294-1","volume":"12","author":"JS Wefel","year":"2011","unstructured":"Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703\u2013708. https:\/\/doi.org\/10.1016\/S1470-2045(10)70294-1","journal-title":"Lancet Oncol"},{"key":"5616_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","volume":"30","author":"M Lange","year":"2019","unstructured":"Lange M, Joly F, Vardy J, Ahles T, Dubois M, Tron L, Winocur G, de Ruiter MB, Castel H (2019) Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol 30:1925\u20131940. https:\/\/doi.org\/10.1093\/annonc\/mdz410","journal-title":"Ann Oncol"},{"key":"5616_CR9","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.ctrv.2012.05.002","volume":"38","author":"AD Hutchinson","year":"2012","unstructured":"Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev 38:926\u2013934. https:\/\/doi.org\/10.1016\/j.ctrv.2012.05.002","journal-title":"Cancer Treat Rev"},{"key":"5616_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11764-017-0656-6","volume":"12","author":"HM Dhillon","year":"2018","unstructured":"Dhillon HM, Tannock IF, Pond GR, Renton C, Rourke SB, Vardy JL (2018) Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy. J Cancer Surviv 12:178\u2013185. https:\/\/doi.org\/10.1007\/s11764-017-0656-6","journal-title":"J Cancer Surviv"},{"key":"5616_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1017\/S1355617713001215","volume":"20","author":"B Collins","year":"2014","unstructured":"Collins B, MacKenzie J, Tasca GA, Scherling C, Smith A (2014) Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy. J Int Neuropsychol Soc 20:370\u2013379. https:\/\/doi.org\/10.1017\/S1355617713001215","journal-title":"J Int Neuropsychol Soc"},{"key":"5616_CR12","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1200\/JCO.2015.63.0905","volume":"33","author":"JL Vardy","year":"2015","unstructured":"Vardy JL, Dhillon HM, Pond GR, Rourke SB, Bekele T, Renton C, Dodd A, Zhang H, Beale P, Clarke S, Tannock IF (2015) Cognitive function in patients with colorectal cancer who do and do not receive chemotherapy: a prospective, longitudinal, controlled study. J Clin Oncol 33:4085\u20134092. https:\/\/doi.org\/10.1200\/JCO.2015.63.0905","journal-title":"J Clin Oncol"},{"key":"5616_CR13","doi-asserted-by":"publisher","first-page":"djx057","DOI":"10.1093\/jnci\/djx057","volume":"109","author":"K Hermelink","year":"2017","unstructured":"Hermelink K, B\u00fchner M, Sckopke P et al (2017) Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients. J Natl Cancer Inst 109:djx057. https:\/\/doi.org\/10.1093\/jnci\/djx057","journal-title":"J Natl Cancer Inst"},{"key":"5616_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrc2073","volume":"7","author":"TA Ahles","year":"2007","unstructured":"Ahles TA, Saykin AJ (2007) Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 7:192\u2013201. https:\/\/doi.org\/10.1038\/nrc2073","journal-title":"Nat Rev Cancer"},{"key":"5616_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09540261.2013.864260","volume":"26","author":"MC Janelsins","year":"2014","unstructured":"Janelsins MC, Kesler SR, Ahles TA, Morrow GR (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry 26:102\u2013113. https:\/\/doi.org\/10.3109\/09540261.2013.864260","journal-title":"Int Rev Psychiatry"},{"key":"5616_CR16","doi-asserted-by":"publisher","first-page":"7159","DOI":"10.1007\/s12035-019-1589-z","volume":"56","author":"C Bagnall-Moreau","year":"2019","unstructured":"Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, Ahles T, Hubbard K (2019) Chemotherapy-induced cognitive impairment is associated with increased inflammation and oxidative damage in the hippocampus. Mol Neurobiol 56:7159\u20137172. https:\/\/doi.org\/10.1007\/s12035-019-1589-z","journal-title":"Mol Neurobiol"},{"key":"5616_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpainsymman.2006.06.011","volume":"33","author":"SR Jacobs","year":"2007","unstructured":"Jacobs SR, Jacobsen PB, Booth-Jones M, Wagner LI, Anasetti C (2007) Evaluation of the Functional Assessment of Cancer Therapy Cognitive scale with hematopoietic stem cell transplant patients. J Pain Symptom Manag 33:13\u201323. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.06.011","journal-title":"J Pain Symptom Manag"},{"key":"5616_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1200\/JCO.2016.67.8201","volume":"35","author":"VJ Bray","year":"2017","unstructured":"Bray VJ, Dhillon HM, Bell ML, Kabourakis M, Fiero MH, Yip D, Boyle F, Price MA, Vardy JL (2017) Evaluation of a web-based cognitive rehabilitation program in cancer survivors reporting cognitive symptoms after chemotherapy. J Clin Oncol 35:217\u2013225. https:\/\/doi.org\/10.1200\/JCO.2016.67.8201","journal-title":"J Clin Oncol"},{"key":"5616_CR19","first-page":"W32","volume":"7","author":"LI Wagner","year":"2009","unstructured":"Wagner LI, Sweet J, Butt Z et al (2009) Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy \u2013 Cognitive Function instrument. J Support Oncol 7:W32\u2013W39","journal-title":"J Support Oncol"},{"key":"5616_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s41687-018-0071-4","volume":"2","author":"ML Bell","year":"2018","unstructured":"Bell ML, Dhillon HM, Bray VJ, Vardy JL (2018) Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog). J Patient-Reported Outcomes 2:48. https:\/\/doi.org\/10.1186\/s41687-018-0071-4","journal-title":"J Patient-Reported Outcomes"},{"key":"5616_CR21","first-page":"13","volume":"34","author":"D Cella","year":"1997","unstructured":"Cella D (1997) The functional assessment of cancer therapy-anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34:13\u201319","journal-title":"Semin Hematol"},{"key":"5616_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"DF Cella","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570\u2013579. https:\/\/doi.org\/10.1200\/JCO.1993.11.3.570","journal-title":"J Clin Oncol"},{"key":"5616_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24:385\u2013396. https:\/\/doi.org\/10.2307\/2136404","journal-title":"J Health Soc Behav"},{"key":"5616_CR24","volume-title":"A user\u2019s guide to the General Health Questionnaire","author":"D Goldberg","year":"1988","unstructured":"Goldberg D, Williams P (1988) A user\u2019s guide to the General Health Questionnaire. NFER-Nelson, Windsor"},{"key":"5616_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00520-006-0037-6","volume":"14","author":"J Vardy","year":"2006","unstructured":"Vardy J, Wong K, Yi QL, Park A, Maruff P, Wagner L, Tannock IF (2006) Assessing cognitive function in cancer patients. Support Care Cancer 14:1111\u20131118. https:\/\/doi.org\/10.1007\/s00520-006-0037-6","journal-title":"Support Care Cancer"},{"key":"5616_CR26","first-page":"36","volume":"15","author":"JC Pendergrass","year":"2018","unstructured":"Pendergrass JC, Targum SD, Harrison JE (2018) Cognitive impairment associated with cancer: a brief review. Innov Clin Neurosci 15:36\u201344","journal-title":"Innov Clin Neurosci"},{"key":"5616_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00042752-200301000-00006","volume":"13","author":"A Collie","year":"2003","unstructured":"Collie A, Maruff P, Makdissi M, McCrory P, McStephen M, Darby D (2003) CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations. Clin J Sport Med 13:28\u201332. https:\/\/doi.org\/10.1097\/00042752-200301000-00006","journal-title":"Clin J Sport Med"},{"key":"5616_CR28","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/13854046.2016.1275819","volume":"31","author":"SK Patel","year":"2017","unstructured":"Patel SK, Meier AM, Fernandez N, Lo TTY, Moore C, Delgado N (2017) Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer. Clin Neuropsychol 31:1375\u20131386. https:\/\/doi.org\/10.1080\/13854046.2016.1275819","journal-title":"Clin Neuropsychol"},{"key":"5616_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.critrevonc.2017.08.001","volume":"118","author":"M Vitali","year":"2017","unstructured":"Vitali M, Ripamonti CI, Roila F, Proto C, Signorelli D, Imbimbo M, Corrao G, Brissa A, Rosaria G, de Braud F, Garassino MC, Lo Russo G (2017) Cognitive impairment and chemotherapy: a brief overview. Crit Rev Oncol Hematol 118:7\u201314. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.08.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"5616_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3322\/caac.21258","volume":"65","author":"JS Wefel","year":"2015","unstructured":"Wefel JS, Kesler SR, Noll KR, Schagen SB (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 65:123\u2013138. https:\/\/doi.org\/10.3322\/caac.21258","journal-title":"CA Cancer J Clin"},{"key":"5616_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.critrevonc.2012.06.005","volume":"84","author":"FYFL De Vos","year":"2012","unstructured":"De Vos FYFL, van Laarhoven HWM, Laven JSE et al (2012) Menopausal status and adjuvant hormonal therapy for breast cancer patients: a practical guideline. Crit Rev Oncol Hematol 84:252\u2013260. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.06.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"5616_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63\u201374. https:\/\/doi.org\/10.1016\/S0885-3924(96)00274-6","journal-title":"J Pain Symptom Manag"},{"key":"5616_CR33","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1198\/016214506000000735","volume":"101","author":"H Zou","year":"2006","unstructured":"Zou H (2006) The adaptive lasso and its oracle properties. J Am Stat Assoc 101:1418\u20131429. https:\/\/doi.org\/10.1198\/016214506000000735","journal-title":"J Am Stat Assoc"},{"key":"5616_CR34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/1471-2407-12-441","volume":"12","author":"J Giese-Davis","year":"2012","unstructured":"Giese-Davis J, Waller A, Carlson LE, Groff S, Zhong L, Neri E, Bachor SM, Adamyk-Simpson J, Rancourt KMS, Dunlop B, Bultz BD (2012) Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age. BMC Cancer 12:441. https:\/\/doi.org\/10.1186\/1471-2407-12-441","journal-title":"BMC Cancer"},{"key":"5616_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11764-018-0692-x","volume":"12","author":"VJ Bray","year":"2018","unstructured":"Bray VJ, Dhillon HM, Vardy JL (2018) Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. J Cancer Surviv 12:537\u2013559. https:\/\/doi.org\/10.1007\/s11764-018-0692-x","journal-title":"J Cancer Surviv"},{"key":"5616_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0035-1555115","volume":"36","author":"DL Murman","year":"2015","unstructured":"Murman DL (2015) The impact of age on cognition. Semin Hear 36:111\u2013121. https:\/\/doi.org\/10.1055\/s-0035-1555115","journal-title":"Semin Hear"},{"key":"5616_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejon.2016.12.007","volume":"27","author":"PJ Oh","year":"2017","unstructured":"Oh PJ (2017) Predictors of cognitive decline in people with cancer undergoing chemotherapy. Eur J Oncol Nurs 27:53\u201359. https:\/\/doi.org\/10.1016\/j.ejon.2016.12.007","journal-title":"Eur J Oncol Nurs"},{"key":"5616_CR38","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1200\/JCO.18.00140","volume":"36","author":"JS Mandelblatt","year":"2018","unstructured":"Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, Graham D, Zhou X, Clapp J, Zhai W, Breen E, Carroll JE, Denduluri N, Dilawari A, Extermann M, Isaacs C, Jacobsen PB, Kobayashi LC, Holohan Nudelman K, Root J, Stern RA, Tometich D, Turner R, VanMeter JW, Saykin AJ, Ahles T (2018) Cancer-related cognitive outcomes among older breast cancer survivors in the thinking and living with cancer study. J Clin Oncol 36:3211\u20133222. https:\/\/doi.org\/10.1200\/JCO.18.00140","journal-title":"J Clin Oncol"},{"key":"5616_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2174\/1874473709666160803101633","volume":"9","author":"MW Campos","year":"2016","unstructured":"Campos MW, Serebrisky D, Castaldelli-Maia JM (2016) Smoking and cognition. Curr Drug Abuse Rev 9:76\u201379. https:\/\/doi.org\/10.2174\/1874473709666160803101633","journal-title":"Curr Drug Abuse Rev"},{"key":"5616_CR40","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10654-013-9840-9","volume":"28","author":"U Mons","year":"2013","unstructured":"Mons U, Sch\u00f6ttker B, M\u00fcller H, Kliegel M, Brenner H (2013) History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol 28:823\u2013831. https:\/\/doi.org\/10.1007\/s10654-013-9840-9","journal-title":"Eur J Epidemiol"},{"key":"5616_CR41","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/pon.3545","volume":"23","author":"TA Ahles","year":"2014","unstructured":"Ahles TA, Li Y, McDonald BC et al (2014) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking. Psychooncology 23:1382\u20131390. https:\/\/doi.org\/10.1002\/pon.3545","journal-title":"Psychooncology"},{"key":"5616_CR42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/pon.742","volume":"12","author":"TA Ahles","year":"2003","unstructured":"Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA (2003) The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612\u2013619. https:\/\/doi.org\/10.1002\/pon.742","journal-title":"Psychooncology"},{"key":"5616_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1326-5-23","volume":"5","author":"S Sabia","year":"2010","unstructured":"Sabia S, Kivimaki M, Kumari M, Shipley MJ, Singh-Manoux A (2010) Effect of apolipoprotein E \u03b54 on the association between health behaviors and cognitive function in late midlife. Mol Neurodegener 5:23. https:\/\/doi.org\/10.1186\/1750-1326-5-23","journal-title":"Mol Neurodegener"},{"key":"5616_CR44","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/pon.4759","volume":"27","author":"H-J Kim","year":"2018","unstructured":"Kim H-J, Barsevick AM, Chan A, Chae J-W (2018) Chemotherapy-associated cognitive impairments in Korean cancer patients: risk factors and functional outcome. Psychooncology 27:1995\u20132001. https:\/\/doi.org\/10.1002\/pon.4759","journal-title":"Psychooncology"},{"key":"5616_CR45","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1212\/WNL.0b013e3181a71193","volume":"72","author":"GA Greendale","year":"2009","unstructured":"Greendale GA, Huang MH, Wight RG, Seeman T, Luetters C, Avis NE, Johnston J, Karlamangla AS (2009) Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 72:1850\u20131857. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a71193","journal-title":"Neurology"},{"key":"5616_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-016-4016-4","volume":"160","author":"A Hennigs","year":"2016","unstructured":"Hennigs A, Riedel F, Marm\u00e9 F, Sinn P, Lindel K, Gondos A, Smetanay K, Golatta M, Sohn C, Schuetz F, Heil J, Schneeweiss A (2016) Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade. Breast Cancer Res Treat 160:491\u2013499. https:\/\/doi.org\/10.1007\/s10549-016-4016-4","journal-title":"Breast Cancer Res Treat"},{"key":"5616_CR47","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamaoncol.2015.4333","volume":"2","author":"SR Kesler","year":"2016","unstructured":"Kesler SR, Blayney DW (2016) Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast cancer survivors. JAMA Oncol 2:185\u2013192. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4333","journal-title":"JAMA Oncol"},{"key":"5616_CR48","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrc2507","volume":"8","author":"B Seruga","year":"2008","unstructured":"Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887\u2013899. https:\/\/doi.org\/10.1038\/nrc2507","journal-title":"Nat Rev Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-020-05616-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05616-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T23:54:59Z","timestamp":1626220499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-020-05616-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5616"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05616-5","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"27 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Institutional ethics approval for the original clinical trial was provided by the Sydney Local Health District\u2014Concord Zone Health Research Ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided written informed consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent to participate included consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Available upon request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}